Pneumococcal disease is especially dangerous for babies older adults, people with certain health conditions. sheet It is also recommended for children for all adults 65 years of age , , adults 2 to 64 years of age with certain health conditions older. 6NH23IP22550) at the Centers for Disease Control Prevention ( CDC) in Atlanta GA. See risks and information benefits. Please check current Medicare billing information. Feb 27, · Tradename: Pneumovax 23. CDC released a new recommendation for the pneumovax use of pneumococcal vaccination among adults. This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases ( Grant cdc No.
Approval: INDICATOI NS AND USAGEPNEUMOVAX 23 is a vaccine indicated for active pneumovax immunization for the. Cdc vaccine information sheet pneumovax. Pneumococcal conjugate vaccine pneumovax ( called PCV13) protects against 13 types sheet of pneumococcal bacteria. pneumovax The CDC develops generic codes for vaccines, maintains CVX codes, codes for Vaccine Information Statements ( VIS). References for PCV13 sheet PPSV23 sheet Intervals between cdc PCV13 PPSV23 Vaccines with emphasis on > 65 years old. VIS inform vaccine recipients - their parents , legal representatives - about cdc the benefits risks of a vaccine. CDC/ NCIRD Subject: ppsv information vaccine information statement Keywords: ppsv cdc ppsv sheet vaccine, ppsv vaccine fact sheet, pneumococcal polysaccharide vaccine, ppsv vaccine information statement, ppsv vaccination, pneumococcal pneumovax polysaccharide vaccine, pneumococcal polysaccharide fact sheet, ppsv fact sheet pneumococcal polysacchari Created Date. Find CDC ACIP pneumococcal vaccine recommendations for PREVNAR 13® Pneumococcal 13- valent Conjugate Vaccine ( Diphtheria CRM197 Protein). A cdc second type of pneumococcal vaccine called PPSV23, may also be given to some children , adults pneumovax including anyone over age 65. Product pneumovax approval information information for Pneumovax 23 - Pneumococcal Vaccine, Polyvalent. PCV13 is routinely given to children at 2 6, , 4 12– 15 months of pneumovax age. The website content is the pneumovax sole responsibility. PNEUMOVAX® 23 ( pneumococcal vaccine sheet polyvalent) Sterile sheet Liquid Vaccine for Intramuscular Subcutaneous cdc Injection cdc Initial U. PNEUMOVAX® 23 ( pronounced " noo- cdc mo- vax 23" ) Generic Name: pneumococcal vaccine polyvalent Read this leaflet before you or your child gets the vaccine called PNEUMOVAX 23. Read the VISs for vaccines that protect against pneumococcal disease: PCV13 vaccine may also be recommended for cdc some older children or adults.Please read the accompanying Patient Information for PNEUMOVAX ® 23 ( Pneumococcal Vaccine Polyvalent) and discuss it with your health care professional. A Vaccine information Information Statement ( VIS) is a one- page produced by the Centers for Disease pneumovax Control , two- sided, information sheet Prevention information ( CDC). Your doctor can give you details. Medicare reimbursement may be different from pneumovax CDC recommendations for immune compromised adults > 65 years old. See full prescribing information for PNEUMOVAX 23. If you would like more information about PNEUMOVAX 23, talk to your health care professional.
Therapeutic Class: Vaccine. Uses For Pneumovax 23. Pneumococcal polyvalent vaccine is an active immunizing agent used to prevent infection by pneumococcal bacteria. It works by causing your body to produce its own protection ( antibodies) against the disease.
cdc vaccine information sheet pneumovax
The following information applies only to the polyvalent 23 pneumococcal vaccine. 4943 — PNEUMOVAX 23 is supplied as a single- dose vial of liquid vaccine, in a box of 10 single- dose vials, color coded with a purple cap and stripe on the vial labels and cartons, NDC.